3rd Quarter - Report

NATIONAL MARROW DONOR PROGRAM for NATIONAL MARROW DONOR PROGRAM

Firm
Client
Income
—
Expenses
$290,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Clinical Trial Modernization Act (House), H.R. 3521. Reauthorization of the Enhanced Advance Premium Tax Credit (House and Senate).

LobbyistCovered position, as disclosed
JESSICA KNUTSON —
ANNE SIMAYTIS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2036 (119th), S. 752 (119th), S. 1227 (119th), H.R. 1509 (119th), S. 925 (119th), H.R. 3521 (119th), H.R. 5160 (119th), H.R. 2491 (119th)

Budget/Appropriations BUD

Continued funding for the C.W. Bill Young Cell Transplantation Program. Increased funding to expand patient access to transplants. Increased medical research funding.

LobbyistCovered position, as disclosed
JESSICA KNUTSON —
ANNE SIMAYTIS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Transportation TRA

Donated bone marrow/cell transportation for life-saving transplant.

LobbyistCovered position, as disclosed
JESSICA KNUTSON —
ANNE SIMAYTIS —

Contacted: Transportation Security Administration (TSA); U.S. Customs & Border Protection

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.